C. Leisser
Impact in
- Obstetrics and Gynecology top 5%
- Pregnancy and preeclampsia studies
-
- Reproductive System and Pregnancy
Papers in
-
- Cell death mechanisms and regulation 7
- Retinoids in leukemia and cellular processes 2
- Wnt/β-catenin signaling in development and cancer 2
- Epigenetics and DNA Methylation 2
- Oncology 5
- Cancer-related Molecular Pathways 3
- Co-authors
- Martin Knöfler (3 shared papers)Stefan Sonderegger (3 shared papers)H Husslein (2 shared papers)Georg Krupitza (13 shared papers)Michael Grusch (10 shared papers)Doris Polgar (7 shared papers)Susanne Maier (6 shared papers)Monika Schindl (1 shared paper)
- Journals
- Cell Death and Differentiation (3 papers)Oncogene (2 papers)Placenta (2 papers)Current Medicinal Chemistry (1 paper)APOPTOSIS (1 paper)
- Partner nations
- AustriaUnited StatesGermany
In The Last Decade
C. Leisser
18 papers receiving 703 citations
Peers
Comparison fields: 5 of 83
- Obstetrics and Gynecology 171
- Immunology 139
- Molecular Biology 379
- Cancer Research 77
- Toxicology 14
Countries citing papers authored by C. Leisser
This map shows the geographic impact of C. Leisser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Leisser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Leisser more than expected).
Fields of papers citing papers by C. Leisser
This network shows the impact of papers produced by C. Leisser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Leisser. The network helps show where C. Leisser may publish in the future.
Co-authors
The 25 scholars most cited alongside C. Leisser, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Level of Id-1 protein expression correlates with poor differentiation, enhanced malignant potential, and more aggressive clinical behavior of epithelial ovarian tumors. | 2003 | 121 |
| 2 | 2007 | 101 | |
| 3 | 2009 | 98 | |
| 4 | 2003 | 71 | |
| 5 | 2002 | 68 | |
| 6 | 2006 | 67 | |
| 7 | 2003 | 31 | |
| 8 | 2001 | 25 | |
| 9 | 2004 | 21 | |
| 10 | 2006 | 21 | |
| 11 | 2009 | 18 | |
| 12 | 2003 | 18 | |
| 13 | 2006 | 15 | |
| 14 | Inhibition of induced chemoresistance by cotreatment with (E)-5-(2-bromovinyl)-2'-deoxyuridine (RP101). | 2003 | 14 |
| 15 | 2002 | 12 | |
| 16 | 2007 | 11 | |
| 17 | 2002 | 2 | |
| 18 | 2001 | 2 |
About C. Leisser
C. Leisser is a scholar working on Molecular Biology, Oncology, Epidemiology, Obstetrics and Gynecology and Immunology, having authored 18 papers that have together received 716 indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (7 papers), Pregnancy and preeclampsia studies (3 papers), Cancer-related Molecular Pathways (3 papers), Retinoids in leukemia and cellular processes (2 papers), Reproductive System and Pregnancy (2 papers), Wnt/β-catenin signaling in development and cancer (2 papers), Epigenetics and DNA Methylation (2 papers) and Acute Lymphoblastic Leukemia research (2 papers). The work is most often cited by research in Obstetrics and Gynecology (171 citations), Immunology (139 citations), Molecular Biology (379 citations), Cancer Research (77 citations) and Toxicology (14 citations). C. Leisser has collaborated with scholars based in Austria, United States and Germany. Frequent co-authors include Martin Knöfler, Stefan Sonderegger, H Husslein, Georg Krupitza, Michael Grusch, Doris Polgar, Susanne Maier, Monika Schindl, Peter Birner and Sebastian F. Schoppmann. Their work appears in journals such as Cell Death and Differentiation, Oncogene, Placenta, Current Medicinal Chemistry and APOPTOSIS.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.